Australia, Aug. 22 -- CELLTRION Inc., owns the trademark (2653029) for 'Ocemma' till April 10, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for human use; antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of inflammatory diseases.]
Type of Mark: Word
Date of Acceptance: June 4
Registration Advertised: Aug. 21
For further details contact JIDAM IP LAW FIRM.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/vie...